Bausch Health Companies (TSE:BHC) Stock Price Up 2.6% – Time to Buy?

Bausch Health Companies Inc. (TSE:BHC) shot up 2.6% during trading on Friday . The company traded as high as C$8.33 and last traded at C$8.17. 315,336 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 520,316 shares. The stock had previously closed at C$7.96.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Barclays upgraded shares of Bausch Health Companies to a “hold” rating in a research note on Monday, December 8th. Raymond James Financial upgraded shares of Bausch Health Companies to a “hold” rating in a research report on Monday, December 15th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Bausch Health Companies Trading Up 2.6%

The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94. The stock has a market cap of C$3.03 billion, a P/E ratio of 8.42, a price-to-earnings-growth ratio of 0.21 and a beta of 0.10. The business’s fifty day simple moving average is C$9.21 and its 200 day simple moving average is C$9.27.

Bausch Health Companies (TSE:BHC) last announced its earnings results on Wednesday, October 29th. The company reported C$0.48 earnings per share (EPS) for the quarter. The company had revenue of C$2.68 billion for the quarter. Bausch Health Companies had a negative net margin of 1.88% and a positive return on equity of 15.87%. As a group, analysts expect that Bausch Health Companies Inc. will post 5.5472637 EPS for the current year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.